CCK and hyperlipidemia: Table 3 presents the distribution of key biochemical and molecular biomarkers—SIRT-1, CCK-8, melatonin, and TAC—stratified by various clinical comorbidities, including smoking status, hypertension, diabetes, cardiovascular disease (CVD), hypothyroidism, hyperlipidemia, and obesity.